{"name":"Immtech Pharmaceuticals, Inc","slug":"immtech-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DB289","genericName":"DB289","slug":"db289","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"DB289","genericName":"DB289","slug":"db289","phase":"phase_2","mechanism":"DB289 is a prodrug that is converted to an active diamidine compound which interferes with DNA binding in parasitic organisms.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWVFlN2xjekhPcGFGZ3kwMFg4V2RGa1hCNklTRTE1R2tvbF9nQW9hTDFqdlp2NlZPcGFvSzZveFpXOUxpUUc2dGo0TjgtUDZtTThJcGtib2lST1NPNzhtRWtoU3ZxTHBUeHBxZ3dvZWRocTg0NjVDbGdRdTBVRjF2TENGaUJscUZ4WnJiaU9QQUdqSmt3NUxFUzBpeXAtUGJwbzJhQmlMSmIzZXpyM29GcnZwQ25JRkdDSzVHcmhIRQ?oc=5","date":"2018-07-03","type":"pipeline","source":"24-7 Press Release Newswire","summary":"Lisa L. McChesney-Harris, Ph.D. Joins the Ranks of Leading Professionals - 24-7 Press Release Newswire","headline":"Lisa L. McChesney-Harris, Ph.D. Joins the Ranks of Leading Professionals - 24-7 Press Release Newswire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE9DZk03YUZNQ2hxcVBnTlBVblFnenJzTW9YdkdVc2N6RjR4Z0c1eUtaZzBiLXpGdFUtLW56S0xmZjdIY1BCXzdJc0c2cGE4aXM?oc=5","date":"2005-08-25","type":"trial","source":"Sudan Tribune","summary":"Trials to begin for new treatment of Trypanosomiasis - Sudan Tribune","headline":"Trials to begin for new treatment of Trypanosomiasis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":10,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}